Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis

Chang Gao; Pei-Yuan Xie; Yu-Guang Dai

doi:10.1007/BF02934698

Your Location：

Home >

Browse articles >

Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis

OriginalPaper | Updated：2021-08-27

- Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis
- Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis
- 中国结合医学杂志（英文版） 1996年2卷第4期页码：281-284
- Affiliations：
  
  The Third Affiliated Hospital of The Third Military Medical University of the PLA,Chongqing
- Author bio：
- Funds：
- DOI：10.1007/BF02934698
  中图分类号：
- 纸质出版日期：1996，
Scan for full text
Gao, C., Xie, PY. & Dai, YG. Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis., CJIM 2, 281–284 (1996). https://doi.org/10.1007/BF02934698

Chang Gao, Pei-Yuan Xie, Yu-Guang Dai. Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis[J]. Chinese Journal of Integrative Medicine, 1996,2(4):281-284.
Gao, C., Xie, PY. & Dai, YG. Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis., CJIM 2, 281–284 (1996). https://doi.org/10.1007/BF02934698 DOI：

Chang Gao, Pei-Yuan Xie, Yu-Guang Dai. Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis[J]. Chinese Journal of Integrative Medicine, 1996,2(4):281-284. DOI： 10.1007/BF02934698.

摘要

Abstract

关键词

Ulcerative ColitisSulfasalazineUlcerative Colitis PatientPuerarinIndirubin

Keywords

Ulcerative ColitisSulfasalazineUlcerative Colitis PatientPuerarinIndirubin

references

Hanauer SB. New drug therapies for inflammatory bowel disease. In: Gary Gitnick, ed. Current gastroenterology. Chicago: Year Book Medicinal Publishers, Inc. 1987: 313–323.

Collawn C, Rubin P, Perez N, et al. Phase II study of the safety efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis. Gastroenterology 1992; 87 (3): 342.

Jayanthi V, Probert CSJ, Sher KS, et al. Current concepts of the etiopathogenesis of inflammatory bowel disease. Am J Gastroenterol 1991; 86 (11): 1566.

Jensen KB, Jarnum S, Koudahl G, et al. Serum orosomucoid in ulcerative colitis. Its relation to activity, protein loss, and turnover of albumin and IgG. Scand J Gastroenterol 1976; 11: 177.

Saverymuttu SH, Peys MB, Chadwick VS, et al. Differing a-cute phase response in Crohn’s disease and ulcerative colitis. Gut 1984: 25: 1166.

Beck IT. Laboratory assessment of inflammatory bowel disease. Dig Dis Sci 1987;32 (12 suppl): 26s.

, 1989: 104.

1992; 17 (6): 377.

FULL TEXT LINK

More>

浏览量

715

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effect of topical application of Puerarin and Propranolol on pial microcirculation of rabbits

Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways

Effects of Modified Sanhuang Decoction (加味三黄汤) enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats

The efficacy and safety of Jitongning Capsule (脊痛宁胶囊) in patients with ankylosing spondylitis

Role of β2-adrenoceptor-β-arrestin2-nuclear factor-κB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis